Tong Ren Tang is an old brand in China's traditional Chinese medicine industry. It was founded in 1669 and has a history of more than 300 years. In August 1992, Beijing Tongrentang Group Co., Ltd. was formally established in China. In June 1997, Beijing Tongrentang Co., Ltd. was solemnly listed and listed on the Shanghai Stock Exchange. In March 2000, Beijing Tongrentang Co., Ltd. sank some of its superior assets to form Beijing Tongrentang Technology Development Co., Ltd., which was listed on the GEM board of the Hong Kong Stock Exchange at the end of October of the same year. After the listing, Tong Ren Tang Technology has maintained good performance and was officially listed on the main board of the Hong Kong Stock Exchange on July 9, 2010, under the stock code 01666. As a high-tech modern traditional Chinese medicine enterprise under the Tongrentang Group, integrating production, supply and marketing, Tongrentang Technology insists on inheriting and carrying forward the tradition of Tongrentang Royal Pharmaceutical, relies on modern pharmaceutical technology, takes “Tongxiu Rende, Health Care” as its mission, and adheres to the pharmaceutical characteristics of “unique formulation, excellent selection, exquisite craftsmanship, and remarkable curative effect”. All production workshops are designed, transformed and operated in strict accordance with GMP standards, and are famous for their high production potential, large dosage reserves, and good product quality. They have all passed the national GMP certification, and also have many passed Australia It is a production line certified by TGA and certified by the Ministry of Health and Welfare of Japan, and the company passed the IS09001 quality system certification as early as 2003. Our company has purchased land in the Beijing Biomedical Industrial Park in Daxing District and invested in the construction of new logistics distribution centers, pre-treatment and processing centers for medicinal herbs, and production centers for liquid preparations and softgels to further increase production capacity and ensure market supply. The products of Beijing Tongrentang Technology Development Co., Ltd. cover more than 20 dosage forms, more than 200 varieties, and have rich reserves of new products already developed and developed. In recent years, according to market demand and changes, Beijing Tongrentang Technology Development Co., Ltd. has increased product technology content, focusing on secondary scientific research. Using new process technologies such as sugar-free production, full extraction concentrate pill technology and tablet film coating, macroporous resin absorption, spray drying, fluidized bed granulation, full extraction concentration, and ultra-fine grinding, it has launched new products such as sugar-free cold clean-up granules, Liuwei Dihuang concentrate pills, and various film-coated tablets, tablets, and softgel capsules. Pellet production line to meet the different needs of patients. It reflects Tong Ren Tang's business philosophy of pragmatism and innovation, putting patients first. In the future, Beijing Tongrentang Technology Development Co., Ltd. will continue to work to modernize traditional Chinese medicine, improve existing traditional Chinese medicine products and develop natural medicines, gradually modernize and internationalize traditional Chinese medicine, expand the marketing network, and promote modern traditional Chinese medicine into the mainstream international pharmaceutical market.
Unlock the Full List